Fosun Pharma Gets License To Test, Market TB Alliance's PaMZ In China
This article was originally published in PharmAsia News
Executive Summary
Shanghai Fosun Pharmaceutical won an exclusive license to develop in China a regimen of tuberculosis drugs created by the TB Alliance and funded by the Bill & Melinda Gates Foundation.